Seasonal analysis of outbreaks of multiple sclerosis and their relation to different climatologic variables [3];Análisis estacional de brotes de esclerosis múltiple y su relación con diferentes variables climatológicas

Revista de Neurologia

Volumn 41, Issue 7, 2005, Pages 446-448

  Guerrero Peral, Ángel Luis ^a   Carrasco Cavia, E ^a   Diez Gonzalez S ^a   Fernandez M J ^a   Martin Polo J M ^a   Bueno Rodriguez V ^a  

^a HOSPITAL RÍO CARRIÓN   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1A INTERFERON; COLECALCIFEROL; GLATIRAMER; IMMUNOMODULATING AGENT; INTERFERON BETA SERINE;

CLIMATE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE PREDISPOSITION; ENVIRONMENTAL TEMPERATURE; HUMAN; IMMUNOMODULATION; IMMUNOREACTIVITY; LATITUDE; LETTER; MULTIPLE SCLEROSIS; PATHOPHYSIOLOGY; PREVALENCE; RETROSPECTIVE STUDY; SEASONAL VARIATION; TEMPERATURE DEPENDENCE; TH1 CELL; TH2 CELL; ADOLESCENT; CHILD; EPIDEMIC; HUMIDITY; SEASON;

ADOLESCENT; CHILD; CLIMATE; DISEASE OUTBREAKS; DISEASE SUSCEPTIBILITY; HUMANS; HUMIDITY; MULTIPLE SCLEROSIS; SEASONS;

EID: 33644807330     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: 10.33588/rn.4107.2005211     Document Type: Letter

References (15)

1. Laborde JM, Dando WA, Teetzen ML. Climate, diffused solar radiation and multiple sclerosis. Soc Sci Med 1988; 27: 231-8.
2. Van der Mei IAF, Ponsonby AL, Blizzard L, Dwyer T. Regional variation in multiple sclerosis prevalence in Australia and its association with ambient ultraviolet radiation. Neuroepidemiology 2001; 20: 168-74.
3. Van der Mei IAF, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, Taylor BV, et al. Past exposure to sun, skin phenotype, and risk of multiple sclerosis: case-control study. BMJ 2003; 327: 316.
4. Partridge JM, Weatherby SJM, Woolmore JA, Highland DJ, Fryer AA, Mann CLA, et al. Susceptibility and outcome in MS. Associations with polymorphisms in pigmentationrelated genes. Neurology 2004; 62: 2323-5.
5. Lucas RM, Ponsonby AL. Ultraviolet radiation and health: friend and foe. Med J Aust 2002; 177: 594-8.
6. McMichael AJ, Hall AJ. Multiple sclerosis and ultraviolet radiation: time to shed more light. Neuroepidemiology 2001; 20: 165-7.
7. Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc 2000; 59: 531-5.
8. Embry AF, Snowdon LR, Vieth R. Vitamin D and seasonal fluctuations of gadolinium-enhancing magnetic resonance imaging lesions in multiple sclerosis. Ann Neurol 2000; 48: 271-2.
9. Wüthrich R, Reider HP. The seasonal incidence of multiple sclerosis in Switzerland. Eur Neurol 1970; 3: 257-64.
10. Shapira K. The seasonal incidence of onset and exacerbations in multiple sclerosis. J Neurol Neurosurg Psychiatry 1959; 22: 285-6.
11. Abella-Corral J, Prieto JM, Dapena-Bolaño D, Iglesias-Gómez S, Noya-García M, Lema M. Variaciones estacionales de los brotes en pacientes con esclerosis múltiple. Rev Neurol 2005; 40: 394-6.
12. Sibley WA, Foley JM. Infection and immunization in multiple sclerosis. Ann NY Acad Sci 1965; 122: 457-68.
13. Ziegler LH. Multiple sclerosis: clinical review and follow-up study. Minn Med 1929; 12: 778-83.
14. Bamford CR, Sibley WA, Thies C. Seasonal variation in multiple sclerosis exacerbations in Arizona. Neurology 1983; 33: 697-701.
15. O'Reilly MAR, O'Reilly PMR. Temporal influences on relapses of multiple sclerosis. Eur Neurol 1991; 31: 391-5.